EUCTR2016-003082-26-AT进行中（未招募）1 期
A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Participants with Advanced Renal Cell CarcinomaMaster Protocol Amendment 07, dated 11-Jan-2022SubProtocol A, Revprot02, dated 08-Feb-2018SubProtocol B, Revprot02, dated 08-Oct-2018SubProtocol C, Protocol Amendment 02, dated 27-May-2021 - FRACTION-RCC
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •For the master protocol:
- •- Advanced Renal Cell Carcinoma
- •- Must have at least 1 lesion with measurable disease
- •- Life expectancy of at least 3 months
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 120
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 180
排除标准
- •For the master protocol:
- •- Patients/subjects with suspected or known central nervous system metastases unless adequately treated
- •- Patients/subjects with autoimmune disease
- •- Patients/subjects who need daily oxygen therapy
研究者
相似试验
进行中（未招募）
1 期
A Study to Test Combination Treatments in People With Advanced Non-Small Cell Lung CancerEUCTR2016-001835-11-ESBristol-Myers Squibb International Corporation1,380
进行中（未招募）
1 期
A Study to Test Combination Treatments in People with Advanced Renal Cell CarcinomaEUCTR2016-003082-26-ITBRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATIO300
进行中（未招募）
1 期
A Study to Test Combination Treatments in People With Advanced Non-Small Cell Lung CancerAdvanced Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 19.0Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-001835-11-FRBristol-Myers Squibb International Corporation295
进行中（未招募）
1 期
A Study to Test Combination Treatments in People With Advanced Non-Small Cell Lung CancerAdvanced Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 20.0Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-001835-11-ATBristol-Myers Squibb International Corporation295
进行中（未招募）
1 期
A Study to Test Combination Treatments in People With Advanced Non-Small Cell Lung Cancer.EUCTR2016-001835-11-ITBRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATIO295